10th International Conference on Tularemia

第十届土拉菌病国际会议

• 批准号: 10722927
• 负责人: Karl E Klose
• 金额: $ 1.82万
• 依托单位: UNIVERSITY OF TEXAS SAN ANTONIO
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-02-01 至 2025-01-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10722927
• 关键词: 10th; International; Conference; Tularemia

SUMMARY/ABSTRACT This proposal seeks support for the 10th International Conference on Tularemia, which will be held from September 25 – 28, 2023, in Grenoble, France. Tularemia is a rapidly progressive and potentially fatal zoonosis of humans caused by the intracellular bacterial pathogen, Francisella tularensis. Because of its low infectious dose and lethality when inhaled, F. tularensis was developed as a bioweapon, and remains a potential bioterrorist agent. Research and understanding of tularemia pathogenesis, diagnosis, treatment, and prevention have been significantly advanced by the International Conferences on Tularemia. Attendance and impact of this meeting has grown steadily in subsequent years. This conference is a unique venue that brings together scientists and interested parties from the U.S., Canada, Scandinavia, Europe, the Middle East, and Japan. CBER/FDA has an ongoing commitment to facilitating development of medical countermeasures for bioterrorism and emerging infectious diseases. Advancing development of medical countermeasures is an explicit goal of this meeting. Senior scientists, clinicians, and trainees at all levels attend; attendees with knowledge and interests outside the Francisella community also bring perspective and instructive comparisons. The conference is designed to provide an environment that fosters collaboration and a free exchange of ideas. Highlights from past meetings include announcing the discoveries of the Francisella pathogenicity island (FPI); the Type VI secretion system encoded by the FPI; development of new animal models; detailed genomic and proteomic characterizations that inform epidemiology of disease and development of new therapeutic options; and identification of immune evasion strategies of the bacterium that advance vaccine development. The 2023 conference will include a keynote address as well as six plenary sessions, poster previews (flash talks) and three poster sessions, and additional opportunities for networking during shared meals and social activities. The six plenary sessions will highlight the latest advances in diagnosis and treatment of tularemia, vaccine development, host responses to infection, epidemiology and bacterial ecology, bacterial physiology and gene regulation, and pathogenesis and cell biology. Each plenary session will be chaired by scientists who are recognized leaders in the field. Over 85% of speakers will be selected based on the merit of submitted abstracts. To achieve these goals, we seek support for meeting logistics that will allow dissemination of research findings as well as professional development of attendees. Specifically, we request support for rental of presentation equipment (audiovisual services and poster boards), conference management and web site development, and travel support for attendees with financial and educational needs.

总结/摘要 该提案寻求对第10届土拉菌病国际会议的支持，该会议将于2012年10月15日至16日举行。 2023年9月25日至28日，法国格勒诺布尔。兔热病是一种进展迅速， 由细胞内细菌病原体土拉弗朗西斯菌引起的人类动物传染病。由于其低 吸入感染剂量和致死率，F.土拉热是作为一种生物武器开发的， 潜在的生物恐怖分子研究和理解兔热病的发病机制，诊断，治疗， 国际土拉菌病会议大大推进了预防工作。出勤和 这次会议的影响在随后几年中不断扩大。这次会议是一个独特的场地，带来了 来自美国的科学家和有关各方，加拿大、斯堪的纳维亚半岛、欧洲、中东和 日本CBER/FDA一直致力于促进医疗对策的制定， 生物恐怖主义和新兴传染病。推进医疗对策的发展是一个 这次会议的明确目标。高级科学家、临床医生和各级培训人员参加; Francisella社区以外的知识和兴趣也带来了视角和指导性 比较。会议旨在提供一个促进合作的环境和一个免费的 交流思想。过去会议的亮点包括宣布弗朗西斯菌的发现 致病岛;致病岛编码的VI型分泌系统;新动物的开发 模型;详细的基因组和蛋白质组学特征，为疾病流行病学提供信息， 开发新的治疗选择;以及鉴定细菌的免疫逃避策略， 推进疫苗研发。2023年的会议将包括一个主题演讲和六个全体会议 会议、海报预览（快速会谈）和三次海报会议，以及建立联系的其他机会 在一起吃饭和社交活动时六次全体会议将突出最新进展， 土拉菌病的诊断和治疗，疫苗开发，宿主对感染的反应，流行病学和 细菌生态学、细菌生理学和基因调控以及致病机理和细胞生物学。每次全体 会议将由该领域公认的领导者科学家主持。超过85%的演讲者将 根据提交的摘要的优点进行选择。为了实现这些目标，我们寻求支持， 后勤，这将使研究成果的传播以及与会者的专业发展。 具体而言，我们请求支持租赁演示设备（视听服务和海报板）， 会议管理和网站开发，并为与会者提供财务和 教育需求。